Journal article · 2026 · Open access
Beyond the Hype of Mendelian Randomization for Rheumatology: What It Is Good for, What It Cannot Do, and How to Read It Critically
The Journal of Rheumatology, jrheum.2026–0574 · Published 1 September 2026 · DOI 10.3899/jrheum.2026-0574
In brief
“Beyond the Hype of Mendelian Randomization for Rheumatology: What It Is Good for, What It Cannot Do, and How to Read It Critically” is a 2026 journal article by Gabriel Chun Yin Sung and 2 co-authors, published in The Journal of Rheumatology. OpenAlex counts 0 citations as of 18 November 2026. It is open access: the full text is free to read at The Journal of Rheumatology.
- Citations
- 0
- References
- 72
- Authors
- 3
Abstract
Mendelian randomization (MR) has become abundant in the literature, with variation in quality and frequent overinterpretation of causality. This creates a problem for clinical readers, reviewers, and editors. Some MR studies can sharpen causal thinking, prioritize drug targets, and challenge misleading observational claims, whereas others are little more than automated exposure outcome scans with causal claims disproportionate to the evidence. MR can strengthen causal inference when randomized controlled trials are impractical and conventional observational studies are vulnerable to confounding, reverse causation, or selection bias. In rheumatology, credible MR can contribute to questions about disease etiology, modifiable risk factors, therapeutic target validation, anticipation of adverse effects, and phenotype validation. However, its interpretation depends on whether (1) the exposure is plausibly instrumentable; (2) the genetic instruments are biologically defensible; (3) assumptions are interrogated in ways appropriate to the design; and (4) findings are triangulated with clinical, observational, experimental, and mechanistic evidence. Instead of recapping all methodological issues of MR, this review aims to help rheumatologists quickly distinguish robust MR from weak or overinterpreted analyses. We provide an accessible framework for reading and triaging MR studies in rheumatology. Papers that use poorly justified instruments, treat medication use as drug target evidence, interpret genetic liability as diagnosis, rely on mechanical sensitivity analyses, ignore prior evidence, or ask no clinically meaningful questions can often be passed over by readers. The goal is not to discourage MR in rheumatology but to raise the standard. Useful MR should clarify causal reasoning rather than simply generate another statistically significant association.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Sung, G. C. Y., Yeung, S. L. A., & Zhao, S. S. (2026). Beyond the Hype of Mendelian Randomization for Rheumatology: What It Is Good for, What It Cannot Do, and How to Read It Critically. The Journal of Rheumatology, jrheum.2026–0574. https://doi.org/10.3899/jrheum.2026-0574
MLA 9
Sung, Gabriel Chun Yin, et al. “Beyond the Hype of Mendelian Randomization for Rheumatology: What It Is Good for, What It Cannot Do, and How to Read It Critically.” The Journal of Rheumatology, 2026, pp. jrheum.2026–0574. https://doi.org/10.3899/jrheum.2026-0574.
Chicago
Sung, Gabriel Chun Yin, Shiu Lun Au Yeung, and Sizheng Steven Zhao. 2026. “Beyond the Hype of Mendelian Randomization for Rheumatology: What It Is Good for, What It Cannot Do, and How to Read It Critically.” The Journal of Rheumatology: jrheum.2026–0574. https://doi.org/10.3899/jrheum.2026-0574.
Harvard
Sung, G. C. Y., Yeung, S. L. A. and Zhao, S. S. (2026) ‘Beyond the Hype of Mendelian Randomization for Rheumatology: What It Is Good for, What It Cannot Do, and How to Read It Critically’, The Journal of Rheumatology, pp. jrheum.2026–0574. doi:10.3899/jrheum.2026-0574.
IEEE
G. C. Y. Sung, S. L. A. Yeung, and S. S. Zhao, “Beyond the Hype of Mendelian Randomization for Rheumatology: What It Is Good for, What It Cannot Do, and How to Read It Critically,” The Journal of Rheumatology, pp. jrheum.2026–0574, 2026, doi: 10.3899/jrheum.2026-0574.
BibTeX
@article{sung2026beyond,
title = {{Beyond the Hype of Mendelian Randomization for Rheumatology: What It Is Good for, What It Cannot Do, and How to Read It Critically}},
author = {Sung, Gabriel Chun Yin and Yeung, Shiu Lun Au and Zhao, Sizheng Steven},
journal = {The Journal of Rheumatology},
year = {2026},
pages = {jrheum.2026--0574},
doi = {10.3899/jrheum.2026-0574},
url = {https://doi.org/10.3899/jrheum.2026-0574}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Mendelian randomization
- rheumatology
- causal inference
- genetic instruments
- drug target validation
- etiology
- modifiable risk factors
- adverse drug reactions
Work with this paper
Most-cited papers in Biochemistry, Genetics and Molecular Biology
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTOliver H. Lowry, NiraJ. Rosebrough, A. Lewis Farr and 1 more · Journal of Biological Chemistry · 1951 · 316,470 citations
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingM Bradford · Analytical Biochemistry · 1976 · 256,780 citations
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodKenneth J. Livak, Thomas D. Schmittgen · Methods · 2001 · 184,418 citations
- Molecular Cloning: A Laboratory ManualJoseph Sambrook, Elisabeth Fritsch, Tom Maniatis · UCLA - Biblioteca de Ciencias de la Salud · 1989 · 133,493 citations
- Basic Local Alignment Search ToolStephen F. Altschul, Warren R. Gish, Webb Miller and 2 more · Journal of Molecular Biology · 1990 · 100,529 citations
All highly cited Biochemistry, Genetics and Molecular Biology papers
Questions about this paper
How do I cite this paper in APA style?
Sung, G. C. Y., Yeung, S. L. A., & Zhao, S. S. (2026). Beyond the Hype of Mendelian Randomization for Rheumatology: What It Is Good for, What It Cannot Do, and How to Read It Critically. The Journal of Rheumatology, jrheum.2026–0574. https://doi.org/10.3899/jrheum.2026-0574
How many times has this paper been cited?
0 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at The Journal of Rheumatology: sign in and open the PDF from this page.
Who wrote this paper?
Gabriel Chun Yin Sung, Shiu Lun Au Yeung, Sizheng Steven Zhao.
What is the DOI of this paper?
10.3899/jrheum.2026-0574, permanently at https://doi.org/10.3899/jrheum.2026-0574. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.